Biopharma

Our analysis of CEO transitions, tenure and backgrounds among S&P 1500 companies, including breakdowns by large-, mid- and small-cap companies.

In the wake of the J.P. Morgan Healthcare Conference, we look at the top leadership trends for the biopharma and biotech industries in 2025.

The biopharmaceutical chain has been pushed to new limits in recent years. We report on the recent CHPI conference in Barcelona and set out our perspective on the top trends and their leadership implications.

Often the “first and only” woman of color in senior roles and executive spaces, high-achieving women of color share advice and stories about their careers.

CEOs are more equipped to deliver long-term value creation when their board balances accountability with support. Here’s how to get the balance right.

While there is no one-size-fits-all model for an effective board-CEO relationship, directors and CEOs told us what has worked for them.